You are here

Home

NOVADIGM THERAPEUTICS, INC.

Company Information
Address
NOVADIGM THERAPEUTICS, INC. 21840 NORMANDIE AVE.
TORRANCE, CA 90502-2047
United States
Information

UEI: CBW9AN2E4WA6

# of Employees: N/A
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 6

  1. Vaccine Strategies for Candidal Infections

    Amount: $1,989,750.00

    DESCRIPTION (provided by applicant): Candida species are opportunistic fungal pathogens that have become among the most common causes of nosocomial infections in the United States and worldwide. Disse ...

    STTRPhase II2009Department of Health and Human Services National Institutes of Health

  2. Recombinant Listeria monocytogenes expressing ALS3: a vaccine against candidiasis

    Amount: $298,561.00

    DESCRIPTION (provided by applicant): Candida species are opportunistic fungal pathogens that are among the most common causes of nosocomial infections. Candida is the third most common organism recove ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health

  3. Creation and validation of a lux-positive Candida strain

    Amount: $203,713.00

    DESCRIPTION (provided by applicant): Candida species have become among the most common causes of nosocomial infections in the United States and worldwide. An estimated 60-70,000 cases of disseminated ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health

  4. Novel Context-Activated Protide Anti-Infectives

    Amount: $222,262.00

    DESCRIPTION (provided by applicant): Antibiotic-resistant strains of Staphylococcus aureus and Pseudomonas aeruginosa are among the most common causes of life-threatening infections in the world. Unfo ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health

  5. Vaccine Strategies for Candidal Infections

    Amount: $128,790.00

    DESCRIPTION (provided by applicant): Candida is a fungus that is among the most common causes of infections in hospitalized patients in the United States and worldwide. Candida spp. are one of the mos ...

    STTRPhase I2006Department of Health and Human Services National Institutes of Health

  6. Vaccine Strategies for Candidal Infections

    Amount: $128,790.00

    DESCRIPTION (provided by applicant): Candida is a fungus that is among the most common causes of infections in hospitalized patients in the United States and worldwide. Candida spp. are one of the mos ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government